Paronychia induced by Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor

被引:27
作者
Nakano, J [1 ]
Nakamura, M [1 ]
机构
[1] Tokuyama Cent Hosp, Dept Dermatol, Tokuyama, Yamaguchi 7458522, Japan
关键词
paronychia; Gefitinib; epidermal growth factor receptor tyrosine kinase inhibitor;
D O I
10.1111/j.1346-8138.2003.tb00387.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:261 / 262
页数:2
相关论文
共 3 条
[1]   Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody [J].
Boucher, KW ;
Davidson, K ;
Mirakhur, B ;
Goldberg, J ;
Heymann, WR .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) :632-633
[2]   Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225 [J].
Busam, KJ ;
Capodieci, P ;
Motzer, R ;
Kiehn, T ;
Phelan, D ;
Halpern, AC .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1169-1176
[3]   EXCESS GRANULATION-TISSUE DURING ETRETINATE THERAPY [J].
HODAK, E ;
DAVID, M ;
FEUERMAN, EJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (06) :1166-1167